Advancing Chronic Kidney Disease Detection and Cardiovascular Risk Reduction in Complex Patients

Program Description

Chronic kidney disease (CKD) is a progressive, life-threatening condition that often coexists with and is significantly worsened by type 2 diabetes (T2D). These interconnected conditions pose significant challenges related to screening, diagnosis, and evidence-based treatment. This webinar will examine the challenges and gaps in CKD management, including issues of underdiagnosis and undertreatment as well as the latest treatment guidelines and recent clinical data supporting novel pharmacotherapies. A key focus will be a detailed discussion of sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists, including data from pivotal clinical trials highlighting their cardiorenal benefits beyond glycemic control. The program will also explore the pharmacist's vital role in optimizing cardiorenal-metabolic care, from implementing screening strategies and ensuring medication access to monitoring outcomes and coordinating team-based care.

Target Audience: Ambulatory care, health system, and specialty pharmacist

Type of Activity: Application
Release date: December 19, 2025
Expiration date: December 19, 2026
Learner level: Foundational and intermediate
Time to complete activity: 1.0 hour
Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Identify patients at increased risk for chronic kidney disease (CKD) and apply guideline-based recommendations for early screening using urine albumin-to-creatinine ratio and estimated glomerular filtration rate
• Explain the cardiovascular risks associated with early-stage CKD and the need for prompt and appropriate intervention
• Determine the role of sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists in managing CKD and reducing cardiovascular risk
• Apply multidisciplinary, team-based approaches to care for patients with cardiorenal-metabolic comorbidities

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hours (0.10 CEU) under the ACPE universal activity number 0290-0000-25-420-H01-P. The activity is available for CE credit through December 19, 2026.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, view the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Disclosures

The following contributors have no relevant financial relationships with ineligible companies to disclose:

Faculty

Craig J. Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS, CACP

Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Dipti Desai, PharmD, MBA, CHCP; Kylie Ferrentino; Susan Pordon; Brianna Winters; and Chloe Taccetta.

Any relevant financial relationships listed for these individuals have been mitigated.

At least one anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with ineligible companies to disclose.

Educational Disclaimer

CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
ceinfo@pharmacytimes.com
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms